Cargando…
Immunohistochemical Characterization of FacioscapulohumeralMuscular Dystrophy Muscle Biopsies
Background: Posited pathological mechanisms in Facioscapulohumeral Muscular Dystrophy (FSHD) include activation in somatic tissue of normally silenced genes, increased susceptibility to oxidative stress, and induction of apoptosis. Objective: To determine the histopathological changes in FSHD muscle...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560242/ https://www.ncbi.nlm.nih.gov/pubmed/26345300 http://dx.doi.org/10.3233/JND-150077 |
_version_ | 1782388892834463744 |
---|---|
author | Statland, Jeffrey M. Odrzywolski, Karen J. Shah, Bharati Henderson, Don Fricke, Alex F. van der Maarel, Silvére M. Tapscott, Stephen J. Tawil, Rabi |
author_facet | Statland, Jeffrey M. Odrzywolski, Karen J. Shah, Bharati Henderson, Don Fricke, Alex F. van der Maarel, Silvére M. Tapscott, Stephen J. Tawil, Rabi |
author_sort | Statland, Jeffrey M. |
collection | PubMed |
description | Background: Posited pathological mechanisms in Facioscapulohumeral Muscular Dystrophy (FSHD) include activation in somatic tissue of normally silenced genes, increased susceptibility to oxidative stress, and induction of apoptosis. Objective: To determine the histopathological changes in FSHD muscle biopsies and compare to possible pathological mechanisms of disease. Methods: We performed a cross-sectional study on quadriceps muscle biopsies from 32 genetically confirmed FSHD participants, compared to healthy volunteers and myotonic dystrophy type 1 as disease controls. Biopsies were divided into groups to evaluate apoptosis rates, capillary density, myonuclear and satellite cell counts. Results: Apoptosis rates were increased in FSHD (n = 10, 0.74% ) compared to myotonic dystrophy type 1 (n = 10, 0.14% , P = 0.003) and healthy volunteers (n = 14, 0.13% , P = 0.002). Apoptosis was higher in FSHD patients with the smallest residual D4Z4 fragments. Capillary density was decreased in FSHD1 (n = 10, 316 capillaries/mm(2)) compared to healthy volunteers (n = 15, 448 capillaries/mm(2), P = 0.001). No differences were seen in myonuclear or satellite cell counts. Conclusions: Preliminary evidence for increased apoptosis rates and reduced capillary density may reflect histopathological correlates of disease activity in FSHD. The molecular-pathological correlates to these changes warrants further investigation. |
format | Online Article Text |
id | pubmed-4560242 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | IOS Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-45602422015-09-04 Immunohistochemical Characterization of FacioscapulohumeralMuscular Dystrophy Muscle Biopsies Statland, Jeffrey M. Odrzywolski, Karen J. Shah, Bharati Henderson, Don Fricke, Alex F. van der Maarel, Silvére M. Tapscott, Stephen J. Tawil, Rabi J Neuromuscul Dis Research Report Background: Posited pathological mechanisms in Facioscapulohumeral Muscular Dystrophy (FSHD) include activation in somatic tissue of normally silenced genes, increased susceptibility to oxidative stress, and induction of apoptosis. Objective: To determine the histopathological changes in FSHD muscle biopsies and compare to possible pathological mechanisms of disease. Methods: We performed a cross-sectional study on quadriceps muscle biopsies from 32 genetically confirmed FSHD participants, compared to healthy volunteers and myotonic dystrophy type 1 as disease controls. Biopsies were divided into groups to evaluate apoptosis rates, capillary density, myonuclear and satellite cell counts. Results: Apoptosis rates were increased in FSHD (n = 10, 0.74% ) compared to myotonic dystrophy type 1 (n = 10, 0.14% , P = 0.003) and healthy volunteers (n = 14, 0.13% , P = 0.002). Apoptosis was higher in FSHD patients with the smallest residual D4Z4 fragments. Capillary density was decreased in FSHD1 (n = 10, 316 capillaries/mm(2)) compared to healthy volunteers (n = 15, 448 capillaries/mm(2), P = 0.001). No differences were seen in myonuclear or satellite cell counts. Conclusions: Preliminary evidence for increased apoptosis rates and reduced capillary density may reflect histopathological correlates of disease activity in FSHD. The molecular-pathological correlates to these changes warrants further investigation. IOS Press 2015-09-02 /pmc/articles/PMC4560242/ /pubmed/26345300 http://dx.doi.org/10.3233/JND-150077 Text en IOS Press and the authors. All rights reserved This article is published online with Open Access and distributed under the terms of the Creative Commons Attribution Non-Commercial License. |
spellingShingle | Research Report Statland, Jeffrey M. Odrzywolski, Karen J. Shah, Bharati Henderson, Don Fricke, Alex F. van der Maarel, Silvére M. Tapscott, Stephen J. Tawil, Rabi Immunohistochemical Characterization of FacioscapulohumeralMuscular Dystrophy Muscle Biopsies |
title | Immunohistochemical Characterization of FacioscapulohumeralMuscular Dystrophy Muscle Biopsies |
title_full | Immunohistochemical Characterization of FacioscapulohumeralMuscular Dystrophy Muscle Biopsies |
title_fullStr | Immunohistochemical Characterization of FacioscapulohumeralMuscular Dystrophy Muscle Biopsies |
title_full_unstemmed | Immunohistochemical Characterization of FacioscapulohumeralMuscular Dystrophy Muscle Biopsies |
title_short | Immunohistochemical Characterization of FacioscapulohumeralMuscular Dystrophy Muscle Biopsies |
title_sort | immunohistochemical characterization of facioscapulohumeralmuscular dystrophy muscle biopsies |
topic | Research Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560242/ https://www.ncbi.nlm.nih.gov/pubmed/26345300 http://dx.doi.org/10.3233/JND-150077 |
work_keys_str_mv | AT statlandjeffreym immunohistochemicalcharacterizationoffacioscapulohumeralmusculardystrophymusclebiopsies AT odrzywolskikarenj immunohistochemicalcharacterizationoffacioscapulohumeralmusculardystrophymusclebiopsies AT shahbharati immunohistochemicalcharacterizationoffacioscapulohumeralmusculardystrophymusclebiopsies AT hendersondon immunohistochemicalcharacterizationoffacioscapulohumeralmusculardystrophymusclebiopsies AT frickealexf immunohistochemicalcharacterizationoffacioscapulohumeralmusculardystrophymusclebiopsies AT vandermaarelsilverem immunohistochemicalcharacterizationoffacioscapulohumeralmusculardystrophymusclebiopsies AT tapscottstephenj immunohistochemicalcharacterizationoffacioscapulohumeralmusculardystrophymusclebiopsies AT tawilrabi immunohistochemicalcharacterizationoffacioscapulohumeralmusculardystrophymusclebiopsies |